Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chuo Ku
Clinical trial register · Japan

Clinical Trials in Chuo Ku, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Nagoya 23 Kashiwa-shi 18 Fukuoka 16 Yokohama 14 Sapporo 13
Narrow the registerReset
Recruitment status
Phase
Site location
Nagoya23 Kashiwa-shi18 Fukuoka16 Yokohama14 Sapporo13
All 92 locations
Target enrolment
to

Trials with a site in Chuo Ku

8 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Amgen
Phase 3
3,200
Yokohama, Chiyoda-ku, Chuo-ku, Hachioji-shi, Minato-ku, Shinjuku-ku, Suginami-ku
2026-07-23
Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
NCT07403721Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen
Phase 1
464
Nagoya, Kashiwa-shi, Chuo-ku, Koto-ku
2026-04-08
Recruiting
Amgen
Phase 1
434
Nagoya, Kashiwa-shi, Chuo-ku
2025-07-31
Active, closed
Amgen
Phase 3
3,853
Yokohama, Chiyoda-ku, Chuo-ku, Hachioji-shi, Minato-ku, Shinjuku-ku, Suginami-ku
2025-03-12
Active, closed
Amgen
Phase 2
61
Nagoya, Kashiwa-shi, Sunto-gun, Chuo-ku, Koto-ku, Wakayama
2024-12-26
Active, closed
Amgen
Phase 1/2
329
Nagoya, Kashiwa-shi, Chuo-ku
2022-02-01
Active, closed
Amgen
Phase 1
269
Kashiwa-shi, Chuo-ku, Wakayama
2017-12-26
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/chuo-ku

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Chuo Ku that also match the filters currently applied.

How many clinical trials are recruiting in Chuo Ku?

3 of the 8 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chuo Ku), 8 studies
PhaseStudiesRecruitingShare
Phase 14250%
Phase 32125%
Phase 1/21012.5%
Phase 21012.5%

Most active sponsors

Lead sponsors with the most studies (Chuo Ku)
Lead sponsorStudiesRecruiting
Amgen83
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.